[1]Hernigou P, Beaujean F, Lambotte JC. Decrease in the mesenchymal stem-cell pool in the proximal femur in corticosteroid-induced osteonecrosis. J Bone Joint Surg Br. 1999;81(2):349-355.[2]Suh KT, Kim SW, Roh HL, et al. Decreased osteogenic differentiation of mesenchymal stem cells in alcohol-induced osteonecrosis. Clin Orthop Relat Res. 2005;(431):220-225.[3]Zhao D, Cui D, Wang B, et al. Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells. Bone. 2012;50(1):325-330.[4]Sen RK, Tripathy SK, Aggarwal S, et al. Early results of core decompression and autologous bone marrow mononuclear cells instillation in femoral head osteonecrosis: a randomized control study. J Arthroplasty. 2012;27(5):679-686.[5]Hernigou P, Poignard A, Zilber S, et al. Cell therapy of hip osteonecrosis with autologous bone marrow grafting. Indian J Orthop. 2009;43(1):40-45.[6]Gangji V, De Maertelaer V, Hauzeur JP. Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: Five year follow-up of a prospective controlled study. Bone. 2011;49(5):1005-1009.[7]Hernigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res. 2002;(405):14-23.[8]Rastogi S, Sankineani SR, Nag HL, et al. Intralesional autologous mesenchymal stem cells in management of osteonecrosis of femur: a preliminary study. Musculoskelet Surg. 2013;97(3):223-228.[9]Nam KW, Kim YL, Yoo JJ, et al. Fate of untreated asymptomatic osteonecrosis of the femoral head. J Bone Joint Surg Am. 2008; 90(3): 477-484.[10]Koo KH, Kim R, Ko GH, et al. Preventing collapse in early osteonecrosis of the femoral head. A randomised clinical trial of core decompression. J Bone Joint Surg Br. 1995;77(6):870-874.[11]Learmonth ID, Maloon S, Dall G. Core decompression for early atraumatic osteonecrosis of the femoral head. J Bone Joint Surg Br. 1990;72(3):387-390.[12]Wang BL, Sun W, Shi ZC, et al. Treatment of nontraumatic osteonecrosis of the femoral head with the implantation of core decompression and concentrated autologous bone marrow containing mononuclear cells. Arch Orthop Trauma Surg. 2010;130(7):859-865.[13]Rastogi S, Sankineani SR, Nag HL, et al. Intralesional autologous mesenchymal stem cells in management of osteonecrosis of femur: a preliminary study. Musculoskelet Surg. 2013;97(3):223-228.[14]Ma Y, Wang T, Liao J, et al. Efficacy of autologous bone marrow buffy coat grafting combined with core decompression in patients with avascular necrosis of femoral head: a prospective, double-blinded, randomized, controlled study. Stem Cell Res Ther. 2014;5(5):115.[15]Papakostidis C, Tosounidis TH, Jones E, et al. The role of "cell therapy" in osteonecrosis of the femoral head. A systematic review of the literature and meta-analysis of 7 studies. Acta Orthop. 2016;87(1):72-78.[16]Tomaru Y, Yoshioka T, Sugaya H, et al. Mid-term results of concentrated autologous bone marrow aspirate transplantation for corticosteroid- associated osteonecrosis of the femoral head in systemic lupus erythematosus. Int Orthop. 2018;42(7):1623-1630.[17]Daltro GC, Fortuna V, de Souza ES, et ak, Efficacy of autologous stem cell-based therapy for osteonecrosis of the femoral head in sickle cell disease: a five-year follow-up study. Stem Cell Res Ther. 2015;6:110.[18]Lim YW, Kim YS, Lee JW, et al. Stem cell implantation for osteonecrosis of the femoral head. Exp Mol Med. 2013;45:e61.[19]王谦,黄国鑫,陈磊,等.髓芯减压联合自体骨髓间充质干细胞移植治疗股骨头坏死:安全和有效性的Meta分析[J].中国组织工程研究,2018,22(17): 2733-2739.[20]李霏霰,吴齐英,李新志,等.髓芯减压术联合自体骨髓干细胞移植治疗老年缺血性股骨头坏死的疗效[J].中国老年学杂志, 2016,36(22): 5671-567.[21]张洋,王楠,杨立枫,等.骨髓间充质干细胞移植联合髓芯减压植骨修复股骨头坏死[J].中国组织工程研究,2015,19(6): 883-890.[22]Hyodo K, Yoshioka T, Sugaya H,et al. Predicting Risk Factors of Total Hip Arthroplasty Conversion after Concentrated Autologous Bone Marrow Aspirate Transplantation for the Treatment of Idiopathic Osteonecrosis of the Femoral Head: A Retrospective Review of 213 Hips at a Mean Follow-up of 5 Years. J Hip Surg 2017; 1(1): 7-13.[23]Nam KW, Kim YL, Yoo JJ, et al. Fate of untreated asymptomatic osteonecrosis of the femoral head. J Bone Joint Surg Am. 2008;90(3): 477-484.[24]Hauzeur JP, De Maertelaer V, Baudoux E, et al. Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: a randomized controlled double-blind trial. Int Orthop. 2018;42(7):1429-1435.[25]Kang JS, Moon KH, Kim BS, et al. Clinical results of auto-iliac cancellous bone grafts combined with implantation of autologous bone marrow cells for osteonecrosis of the femoral head: a minimum 5-year follow-up. Yonsei Med J. 2013;54(2):510-515.[26]Tabatabaee RM, Saberi S, Parvizi J, et al. Combining Concentrated Autologous Bone Marrow Stem Cells Injection With Core Decompression Improves Outcome for Patients with Early-Stage Osteonecrosis of the Femoral Head: A Comparative Study. J Arthroplasty. 2015;30(9 Suppl): 11-15.[27]Chen C, Qu Z, Yin X, et al. Efficacy of umbilical cord-derived mesenchymal stem cell-based therapy for osteonecrosis of the femoral head: A three-year follow-up study. Mol Med Rep. 2016;14(5):4209-4215.[28]Calori GM, Mazza E, Colombo M, et al. Treatment of AVN using the induction chamber technique and a biological-based approach: indications and clinical results. Injury. 2014;45(2):369-373.[29]Liu Y, Liu S, Su X. Core decompression and implantation of bone marrow mononuclear cells with porous hydroxylapatite composite filler for the treatment of osteonecrosis of the femoral head. Arch Orthop Trauma Surg. 2013;133(1):125-133.[30]Kuroda Y, Asada R, So K, et al. A pilot study of regenerative therapy using controlled release of recombinant human fibroblast growth factor for patients with pre-collapse osteonecrosis of the femoral head. Int Orthop. 2016;40(8):1747-1754.[31]Liu X, Li Q, Niu X, et al. Exosomes Secreted from Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Prevent Osteonecrosis of the Femoral Head by Promoting Angiogenesis. Int J Biol Sci. 2017;13(2):232-244. |